67 related articles for article (PubMed ID: 2765107)
1. Micronized emulsion for controlled release of physostigmine after oral administration. Part II. Release characteristics and pharmacological evaluation.
Benita S; Friedman D; Pathak YV; Kleinstern J
Drug Des Deliv; 1989 Mar; 4(2):143-53. PubMed ID: 2765107
[TBL] [Abstract][Full Text] [Related]
2. Micronized emulsion for controlled release of physostigmine after oral administration. Part I. Formulation design.
Friedman D; Pathak YV; Benita S
Drug Des Deliv; 1989 Mar; 4(2):135-42. PubMed ID: 2765106
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evaluation of an injectable prolonged release emulsion of physostigmine in rabbits.
Benita S; Friedman D; Weinstock M
J Pharm Pharmacol; 1986 Sep; 38(9):653-8. PubMed ID: 2877064
[TBL] [Abstract][Full Text] [Related]
4. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
[TBL] [Abstract][Full Text] [Related]
5. Bupivacaine containing dry emulsion can prolong epidural anesthetic effects in rabbits.
Dollo G; Le Corre P; Chevanne F; Le Verge R
Eur J Pharm Sci; 2004 May; 22(1):63-70. PubMed ID: 15113584
[TBL] [Abstract][Full Text] [Related]
6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
Ahmed IS; Aboul-Einien MH
Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
[TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of tablets and capsules containing spray-dried o/w-emulsions for oral delivery of poorly soluble drugs.
Hansen T; Holm P; Rohde M; Schultz K
Int J Pharm; 2005 Apr; 293(1-2):203-11. PubMed ID: 15778058
[TBL] [Abstract][Full Text] [Related]
11. Per-oral controlled release dosage form of theophylline using soybean protein.
Machida Y; Tokumura T; Nagai T
Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
[TBL] [Abstract][Full Text] [Related]
12. Degradation of kinetically-stable o/w emulsions.
Capek I
Adv Colloid Interface Sci; 2004 Mar; 107(2-3):125-55. PubMed ID: 15026289
[TBL] [Abstract][Full Text] [Related]
13. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
14. A mathematical model of volatile release in mouth from the dispersion of gelled emulsion particles.
Lian G; Malone ME; Homan JE; Norton IT
J Control Release; 2004 Jul; 98(1):139-55. PubMed ID: 15245896
[TBL] [Abstract][Full Text] [Related]
15. An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier.
Vasiljevic D; Parojcic J; Primorac M; Vuleta G
Int J Pharm; 2006 Feb; 309(1-2):171-7. PubMed ID: 16406403
[TBL] [Abstract][Full Text] [Related]
16. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.
Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T
J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477
[TBL] [Abstract][Full Text] [Related]
17. Preparation and performance evaluation of saquinavir laden cationic submicron emulsions.
Jain V; Prasad V; Jadhav P; Mishra PR
Drug Deliv; 2009 Jan; 16(1):37-44. PubMed ID: 19555307
[TBL] [Abstract][Full Text] [Related]
18. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug.
Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS
Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547
[TBL] [Abstract][Full Text] [Related]
20. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
Brouillet F; Bataille B; Cartilier L
Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
